Search results
Discover how eCOA software enhances clinical trials with real-time data capture, faster, scalable builds, and a modern, consumer-grade experience. Learn why cloud-based solutions improve efficiency, compliance, and patient engagement.
Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.
Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.
Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.
Medable is an end-to-end, cloud-based platform with a scalable suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient workflows and patient-focused data collection. Click to learn more.
Gain a quick overview of what top trends and topics dominated DIA 2023.
With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.
This blog describes software as a service and how the life sciences industry uses it today.
Discover how eCOA software is reshaping modern clinical trials by enabling decentralized designs, enhancing patient adherence, and optimizing data collection through real-time digital tools. Learn how cloud-based solutions and AI are driving the next evolution in clinical research.
Discover a unified digital platform for clinical trials with best-in-class decentralized and eCOA software. Streamline data collection, scale globally, and deliver smarter, faster results.
Discover how Medable helped digitize and standardize a client's participant pain body maps for a diabetic polyneuropathy trial.
For years, sponsors and CROs have lamented the lack of control and transparency, particularly with technology, during study launches. See how Medable Studio solves these issues, and others around assessments, instruments, and translations.
See what happened at this year's annual J.P.M. week with this blog.
A summary of JPM2024 news, trends, and highlights that made waves during this year’s conference.
Your questions about decentralized clinical trials answered. Read to learn more about Medable and its cloud based, SaaS tools, from total consent, ecoas, and more
Uncover some of the more common challenges and preferences of patients and their caregivers.
See why many of the top pharma are focused on building the "next model" of clinical trial conduct using foundational platforms.
Learn how Medable's eCOA (electronic clinical outcome assessment) solution was able to deliver >90% adherence and scalability for a top pharmaceutical weight management clinical trial.
The clinical trial landscape is experiencing a data revolution. According to the Tufts 2020 report, over two-thirds of sponsors are now using or piloting at least four different data sources in their clinical trials, with almost 14% using six. This uptick comes from a diverse pool of data sources, such as eConsent (electronic informed consent) data, eCOA data, mHealth data, smartphone data, eSource data, etc., and reflects the industry's move towards more comprehensive and nuanced data collection.
Contact Medable for a demo and to learn more about DCT certification, careers, and support. Medable, per Everest Group Peak matrix, is the top decentralized clinical trial company.
The rise of SaaS has transformed industries, including life sciences, by enabling new possibilities. For instance, Salesforce revolutionized how organizations managed their customers and future clients with its cloud-based software, enhancing accessibility and collaboration. Similarly, Canva made graphic design tools accessible to all, empowering professionals and casual users alike.
A top 10 pharmaceutical company looked to Medable to streamline participant burden and enhance site and team experience in oncology trials, while establishing a scalable template for future trials in oncology and other areas.
Learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
Join Medable's Mohammed Ali, Chief Domain Expert and Shubha Govil, SVP of Product Management,Platform to hear how top pharma teams have adopted digital technology across a platform to reduce costs and accelerate time to market.
Medable worked with a top 5 pharma company to increase the safety of patients as anti-cancer treatments may cause pulmonary toxicity, ranging from asymptomatic radiological changes to respiratory failure, and is considered a common side effect.
In this webinar, learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
Streamline your clinical trial and generate high-quality data with a #1 rated, easy-to-use platform, offered in over 60 countries and 120 languages. Book a demo to learn more.
See how customers have had success with Medable, our trial platform, and our teams.
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Electronic clinical outcome assessments (eCOAs) have revolutionized clinical trials, offering significant advantages over traditional paper-based methods. By enhancing data quality, streamlining data collection, improving patient engagement, and enabling real-time data access, eCOAs have become indispensable tools in modern clinical research. However, successful eCOA implementation requires careful planning, meticulous execution, and a deep understanding of the regulatory landscape. This comprehensive guide provides a detailed roadmap for implementing eCOAs effectively, covering key aspects from study design to future trends.
Learn how we can help you navigate the complexities of clinical operations so that you can meet your study's milestones faster and easier.
A top-10 global pharmaceutical company partnered with Medable for their pivotal Phase III diabetes study in the highly competitive market. Recognizing the inefficiencies in traditional study delivery and closeout processes, the company leveraged Medable’s expertise to accelerate timelines, enhance operational efficiency, and achieve a faster time to market for this high-profile therapy.
A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. Recognizing Japan’s distinct regulatory, cultural, and logistical landscape, the company partnered with Medable to develop an initiative to enhance the region’s patient and site experience.
Gain a partner that helps bring speed and savings to your trials with a single platform that scales to support your study and SMEs that are here for your needs from beginning to end.
See how a pharmaceutical company used data gathered during the informed consent process to pre-populate their site's systems, as well as their own.
See how Medable helped one customer achieve their fastest enrollment ever.
See how Medable was able to increase study startup speed for one customer by 50%.
The partnership between Medable, U.S. Renal Care, and the top ten pharmaceutical sponsor exemplifies the transformative power of Medable’s Total Consent solution in clinical trials. By overcoming common misconceptions around participant age, cost, and complexity, Medable’s platform proved to be a flexible, fast, and efficient solution for the elderly renal care population. U.S. Renal Care sought to use Medable’s Total Consent (Medable’s eConsent solution) for an investigator-initiated trial. The phase 4 trial, which was funded by a top 10 pharmaceutical company, sought to enroll elderly participants suffering from Anemia ESKD (End Stage Kidney Disease) across 476 site users. The trial would be managed by three central principal investigators (PIs).
A top-10 global pharmaceutical company came to Medable looking to standardize and scale their weight management trials. The trial was driven by a master protocol with multiple sub-studies across 70+ research sites. The partner was concerned about the participant and site experience, particularly participant enrollment and study startup timelines, as the trial required participants to enroll through the master protocol before enrolling into a sub-study. Read ahead to see how Medable accomplished this and more.